We’ve put some small files called cookies on your device to make our site work.
We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site.
Let us know if this is OK. We’ll use a cookie to save your choice. You can read more about our cookies before you choose.
Change my preferences
I'm OK with analytics cookies
On behalf of the national Regional Medicines Optimisation Committees (RMOCs) system, RMOC (South) has developed practical recommendations for safe ophthalmology monitoring of patients who are receiving long term hydroxychloroquine or chloroquine. The document outlines the risks of retinopathy and sets out a structured approach for health professionals to manage these risks.